Ventana Biotech Stock Cash Per Share
| VNTA Stock | USD 0.0004 0.00 0.00% |
Ventana Biotech fundamentals help investors to digest information that contributes to Ventana Biotech's financial success or failures. It also enables traders to predict the movement of Ventana Pink Sheet. The fundamental analysis module provides a way to measure Ventana Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ventana Biotech pink sheet.
Ventana |
Ventana Biotech Company Cash Per Share Analysis
Ventana Biotech's Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
| Competition |
In accordance with the recently published financial statements, Ventana Biotech has a Cash Per Share of 0.0 times. This is 100.0% lower than that of the Financial Services sector and about the same as Shell Companies (which currently averages 0.0) industry. The cash per share for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Money Managers Now
Money ManagersScreen money managers from public funds and ETFs managed around the world |
| All Next | Launch Module |
Ventana Fundamentals
| Current Valuation | 165.2 K | |||
| Shares Outstanding | 55.07 M | |||
| Price To Earning | (1.00) X | |||
| Gross Profit | (260) | |||
| EBITDA | (36.71 K) | |||
| Net Income | (47.08 K) | |||
| Current Ratio | 0.02 X | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (54.01 K) | |||
| Earnings Per Share | (0) X | |||
| Beta | -2.08 | |||
| Market Capitalization | 192.73 K |
About Ventana Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ventana Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ventana Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ventana Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Ventana Pink Sheet
Ventana Biotech financial ratios help investors to determine whether Ventana Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ventana with respect to the benefits of owning Ventana Biotech security.